Wat is de prijs voor Celltrion Healthcare Co., Ltd. (091990)

Het prijs van Celltrion Healthcare Co., Ltd. (091990) is $57.75

Wat is de marktkapitalisatie voor Celltrion Healthcare Co., Ltd. (091990)

Marktkapitalisatie voorCelltrion Healthcare Co., Ltd. (091990) is $9.42B

Celltrion Healthcare Co., Ltd. (091990) Prijsgeschiedenis

Celltrion Healthcare Co., Ltd. is a global pharmaceutical company focused on the development, manufacturing, and distribution of biosimilar and biological therapeutic agents for patients around the globe. Its product lineup includes Remsima, a monoclonal antibody biosimilar used to treat various inflammatory and autoimmune diseases such as rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, Crohn's disease in both adults and children, psoriasis, and psoriatic arthritis. Another significant offering, Truxima, targets conditions like lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis, microscopic polyangiitis, and rheumatoid arthritis. Herzuma is prescribed for metastatic breast cancer, early-stage breast cancer, and metastatic gastric cancer. Additionally, Remsima SC provides a treatment option for rheumatoid arthritis. Founded in 1999, the enterprise was initially known as Nexol, Inc. before rebranding to Celltrion Healthcare Co., Ltd. in March 2009. The firm's corporate headquarters are situated in Incheon, South Korea.

Jaar	Prestaties
2024	1.85%
2023	14.18%
2022	-28.39%
2021	0.00%

Jaar

Prestaties

2024

1.85%

2023

14.18%

2022

-28.39%

2021

0.00%

Bedrijf	Aandelenkoers	Verandering 1jr%	Land
Vertex Pharmaceuticals Incorporated VRTX.US	$554.72	42.62%	US
Argenx SE ARGX.US	$1.03K	51.70%	NL
Moderna, Inc. MRNA.US	$158.83	526.55%	US
CSL Limited CSL.AX	$122.47	-12.71%	AU
Lonza Group AG LONN.SW	$772.27	8.67%	CH

Bedrijf

Aandelenkoers

Verandering 1jr%

Land